A case of GLI1-altered mesenchymal tumour with NCOR2(exon 1)::GLI1(exon 4) fusion has been reported, which showed no recurrent disease at 4 months follow-up [3]. This evidence concerns the gene GLI1 and mesenchymal cell neoplasm.